Literature DB >> 27447126

MYC and BCL2 evaluation in routine diagnostics of aggressive B-cell lymphomas - presentation of a work-flow and the experience with 248 cases.

Thomas Menter1,2, Hanine Medani1, Raida Ahmad1, Rashpal Flora1, Pritesh Trivedi1, Alistair Reid1, Kikkeri N Naresh1.   

Abstract

Entities:  

Keywords:  zzm321990MYCzzm321990; diffuse large B-cell lymphoma; double-hit lymphomas; fluorescence in situ hybridization; immunohistochemistry

Mesh：

Substances：

Year:  2016        PMID： 27447126     DOI： 10.1111/bjh.14250

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients.

Authors:  Maria R Ambrosio; Stefano Lazzi; Giuseppe Lo Bello; Raffaella Santi; Leonardo Del Porro; Maria M de Santi; Raffaella Guazzo; Lucia Mundo; Luigi Rigacci; Sofia Kovalchuck; Noel Onyango; Alberto Fabbri; Emanuele Cencini; Pier Luigi Zinzani; Francesco Zaja; Francesco Angrilli; Caterina Stelitano; Maria G Cabras; Giuseppe Spataro; Roshanak Bob; Thomas Menter; Massimo Granai; Gabriele Cevenini; Kikkeri N Naresh; Harald Stein; Elena Sabattini; Lorenzo Leoncini
Journal:  Haematologica       Date:  2018-06-28       Impact factor: 9.941

Review 2.  The clinicopathologic spectrum of mature aggressive B cell lymphomas.

Authors:  Lisa Rimsza; Stefania Pittaluga; Stephan Dirnhofer; Christiane Copie-Bergman; Laurence de Leval; Fabio Facchetti; Stefano Pileri; Andreas Rosenwald; Andrew Wotherspoon; Falko Fend
Journal:  Virchows Arch       Date:  2017-08-26       Impact factor: 4.064
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.